一般的な便中病原体の分子診断検査
Molecular diagnostic testing for common stool pathogens
G. Trafford*, N. Ratnaraja, N. Wickramasinghe
*Heart of England Foundation Trust, UK
Journal of Hospital Infection (2015) 90, 196-198
No abstract.
サマリー原文(英語)はこちら
監訳者コメント:
便中の腸管病原体の検出に、日常的な検査として遺伝子検査が用いられるケースはこれまで少なかった。しかしながら、従来法は感度や手間、費用などの点で制約が大きかったのも事実である。本稿は、PCR 法を用いる長所、ピットフォール、結果の解釈、コスト比較など、実用化と感染対策への応用に向けた課題について述べている。
同カテゴリの記事
Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000-2006: use of passive surveillance of susceptibility phenotypes
Clostridioides difficile infection after pneumonia in elderly patients: which antibiotic is at lower risk?
P. Bonnassot*, J. Barben, J. Tetu, J. Bador, P. Bonniaud, P. Manckoundia, A. Putot
*Hospital of Champmaillot, University Hospital, France
Journal of Hospital Infection (2020) 105, 527-533
Super-factors associated with transmission of occupational COVID-19 infection among healthcare staff in Wuhan, China
Y. Wang*, W. Wu, Z. Cheng, X. Tan, Z. Yang, X. Zeng, B. Mei, Z. Ni, X. Wang
*Zhongnan Hospital of Wuhan University, China
Journal of Hospital Infection (2020) 106, 25-34
Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor
Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus
S. Haessler*, T. Mackenzie, K.B. Kirkland
*Dartmouth Medical School, USA
Journal of Hospital Infection (2008) 69, 39-45
